Quantcast

Lipitor improves kidney function in clinical trial

March 13, 2006

NEW YORK (Reuters) – Pfizer Inc. on Monday said its Lipitor
cholesterol medicine improved kidney function in patients with
heart disease in a large clinical study.

The drugmaker also said improvement in kidney function was
significantly greater among patients taking the 80 milligram
highest dose of Lipitor, the world’s top-selling prescription
drug.

The data from the 8,000-patient study was presented at the
American College of Cardiology annual scientific meeting in
Atlanta.


Source: reuters



comments powered by Disqus